Sex Differences in Supplement Response: Iron, Creatine, Hormonal Context, and What Research Shows

Most supplement research has been conducted predominantly in men, and many dosing recommendations were derived from trials that excluded women or failed to analyze results by sex. This is a significant gap. Biological sex — and hormonal status within each sex — influences pharmacokinetics (absorption, distribution, metabolism, excretion), pharmacodynamics (receptor sensitivity, downstream signaling), and the underlying deficiency landscape that determines when supplementation is most needed.

This article maps the key sex differences in supplement response that have meaningful clinical implications.

Iron: The Clearest Sex Divergence

Iron is the most stark example of sex-divergent supplement need. Premenopausal women lose 1.5-2 mg of iron per day on average through menstruation, versus 1 mg/day in men. This drives substantially different daily requirements: 18 mg/day for premenopausal women versus 8 mg/day for men and postmenopausal women.

Iron deficiency without anemia is common — affecting up to 15-20% of premenopausal women and less than 5% of men in developed countries. Symptoms include fatigue, impaired exercise performance, cognitive fog, and cold intolerance, all of which can precede changes in hemoglobin.

Critically, iron excess is harmful: unneeded iron supplementation generates reactive oxygen species, promotes oxidative damage, and in men has been associated with increased cardiovascular risk via ferroptosis and inflammation. Men should not supplement iron routinely without confirmed deficiency (low ferritin, typically below 30 mcg/L). For postmenopausal women, the iron requirement drops to match men.

Testing: serum ferritin (below 30 mcg/L is suboptimal; below 12 mcg/L is deficient) plus TIBC and transferrin saturation to distinguish iron deficiency from anemia of chronic disease.

Creatine: Differential Baseline and Response Pattern

Women have substantially lower intramuscular creatine stores than men — approximately 70-80% of male levels, partly explained by lower muscle mass but also by dietary patterns (creatine is primarily found in meat and fish). This means women may have more room to benefit from creatine supplementation relative to baseline.

A 2021 review found that creatine supplementation in women produced equivalent percentage improvements in strength and power relative to men, suggesting the absolute effect size is similar despite the lower starting point. However, women's muscle mass gains per gram of creatine gained may differ due to hormonal environment (lower testosterone attenuates hypertrophic response).

Creatine also has expanding evidence in women's cognitive health and mood — creatine supports ATP synthesis in neurons, and low creatine status is associated with depression, particularly in women. A 2012 RCT found that creatine supplementation (3g/day) enhanced the antidepressant response to escitalopram specifically in women. This sex-specific finding has not been widely replicated but is biologically plausible given hormonal modulation of brain creatine metabolism.

Dosing: standard 3-5g/day of creatine monohydrate applies to both sexes; no sex-specific dose adjustment is evidence-based, though women's lower starting stores may mean a loading phase is more useful for faster saturation.

Vitamin D: Similar Deficiency Rates, Different Consequences

Vitamin D deficiency rates are broadly similar between men and women in most populations. However, sex-specific consequences diverge. In women, low vitamin D is associated with higher fracture risk (due to interaction with estrogen on bone metabolism), polycystic ovarian syndrome (PCOS) severity, and premenstrual symptom intensity. In postmenopausal women, vitamin D deficiency is strongly linked to both bone density loss and muscle weakness.

In men, vitamin D influences testosterone synthesis — low vitamin D is associated with lower testosterone in several cross-sectional studies, and a small RCT found that vitamin D supplementation in deficient men (3332 IU/day for 12 months) increased total testosterone by approximately 20%. This association has not been replicated consistently.

Target 25-OH vitamin D: 40-60 ng/mL for both sexes. Supplementation form and dose do not require sex-specific adjustment, but monitoring the sex-specific consequences of deficiency (bone in women, testosterone in men) helps prioritize testing.

B12 and Hormonal Contraceptive Use

Oral contraceptive pills (OCPs) and certain hormone-containing IUDs reduce serum B12, B6, folate, and magnesium through multiple mechanisms including altered absorption, increased renal clearance, and potential competition at binding sites. Premenopausal women on hormonal contraceptives should be aware of this and consider baseline testing.

B12 absorption declines with age in both sexes due to reduced gastric acid and intrinsic factor secretion, but women are at higher absolute risk of pernicious anemia (an autoimmune cause of B12 deficiency) — approximately 3-fold more common in women.

Omega-3 Fatty Acids: Conversion Efficiency and Dosing

Women show approximately 2-3 fold higher conversion of ALA (plant-derived omega-3) to EPA and DHA compared to men. This is an estrogen-mediated effect — estrogen upregulates elongase and desaturase enzymes in the conversion pathway. Consequently, plant-based omega-3 sources may provide somewhat more DHA to women than men at equivalent intakes. This reduces but does not eliminate the advantage of direct DHA/EPA supplementation.

For cardiovascular protection and cognitive health, direct EPA+DHA supplementation is still preferred over ALA alone, but women who are plant-based can be reassured that their conversion efficiency is superior to men's.

Adaptogenic Herbs: Hormonal Context Matters

Ashwagandha, rhodiola, and similar adaptogens are generally studied in mixed-sex or predominantly male populations. Ashwagandha has demonstrated cortisol reduction and testosterone increases in men; its effects on estrogen or other hormonal markers in women are less characterized. One concern that has been raised but not confirmed is thyroid stimulation — ashwagandha has shown TSH reduction and T4 increase in small studies, which in women (who have a higher background rate of thyroid conditions) warrants monitoring if used long-term.

Maca root has sex-specific traditional use and some trial evidence specifically for menopausal symptom reduction, although the evidence base is small.

When Hormonal Status Changes Everything

Post-menopause in women and late-onset hypogonadism in men represent distinct hormonal contexts that alter supplement needs across multiple categories:

• Postmenopausal women: calcium requirement increases (1200 vs 1000 mg/day), bone-protecting vitamin D and K2 become more pressing, iron requirement drops to match men's
• Men with hypogonadism: zinc, ashwagandha, and vitamin D may have greater effect on testosterone versus eugonadal men
• Pregnant and lactating women: iron, DHA, iodine, and folate requirements are substantially elevated; many supplements are contraindicated in these states

Related pages: Creatine, Iron, Vitamin D3, Sarcopenia Age Related Muscle Loss, Creatine Protein Older Adults Strength

Evidence Limits and What We Still Need

The fundamental problem in this field is underrepresentation of women in supplement trials and near-absence of sex-stratified analysis in existing data. Most creatine RCTs have fewer than 20 women. Hormonal context within women (menstrual phase, contraceptive use, menopausal status) is rarely documented or controlled. Most pharmacokinetic data for supplements come from studies in men. Sex-specific optimal dosing ranges for most supplements have never been empirically determined. Until trials are powered and designed to characterize sex differences, recommendations remain extrapolated from predominantly male data with acknowledged uncertainty.

Sources

1. Smith-Ryan AE, et al. Creatine supplementation in women's health: a lifespan perspective. Nutrients. 2021. https://pubmed.ncbi.nlm.nih.gov/34073597/
2. Dominguez LJ, et al. Iron metabolism, anemia, and aging. J Nutr Health Aging. 2021. https://pubmed.ncbi.nlm.nih.gov/34373027/
3. Nair R, et al. Vitamin D: the "sunshine" vitamin. J Pharmacol Pharmacother. 2012. https://pubmed.ncbi.nlm.nih.gov/23378856/
4. Pilz S, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. 2011. https://pubmed.ncbi.nlm.nih.gov/21154195/
5. Kiecolt-Glaser JK, et al. Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: a randomized controlled trial. Brain Behav Immun. 2013. https://pubmed.ncbi.nlm.nih.gov/23010483/
6. Balk E, et al. B vitamins and berries and age-related neurodegenerative disorders. Evidence Report/Technology Assessment. 2006. https://pubmed.ncbi.nlm.nih.gov/33536765/